EU agency sees no new risks with combined contraceptives

LONDON (Reuters) - European drug regulators said on Friday there was no reason for women to stop using combined contraceptives like Bayer's Meliane (gestodene plus ethinyl estradiol) or Yasmin (drospirenone plus ethinyl estradiol) since there was no new evidence pointing to safety risks.
Source: Modern Medicine - Category: Journals (General) Source Type: news